>
Asterias Biotherapeutics Inc logo

AST - Asterias Biotherapeutics Inc Share Price

$0.945 0.0  0.0%

Last Trade - 07/03/19

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £523k
Position in Universe th / 6858
Bullish
Bearish
Unlock AST Revenue
Momentum
Relative Strength (%)
1m -0.37%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2012 2013 2014 2015 2016 2017 2018E 2019E CAGR / Avg
0.000 0.000 1.22 3.58 6.95 4.04 0.83 0.48
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2018,Asterias Biotherapeutics Inc revenues decreased 82% to$703K. Net loss decreased 37% to $13.7M. Revenues reflectGrant income decrease from $3.7M to $0K. Lower net lossreflects Research and development - Balancing val decreaseof 47% to $9.7M (expense), General and administrative -Other decrease of 28% to $4.8M (expense), Stock-basedCompensation in R&D decrease of 45% to $1.1M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

AST Revenue Unlock AST Revenue

Net Income

AST Net Income Unlock AST Revenue

Normalised EPS

AST Normalised EPS Unlock AST Revenue

PE Ratio Range

AST PE Ratio Range Unlock AST Revenue

Dividend Yield Range

AST Dividend Yield Range Unlock AST Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
AST EPS Forecasts Unlock AST Revenue
Profile Summary

Asterias Biotherapeutics, Inc. is a biotechnology company. The Company is engaged in developing and commercializing therapies in the fields of cell therapy and regenerative medicine. The Company has over two technology platforms. The first is an immunotherapy platform to teach cancer patients' immune systems to attack their tumors. The second is pluripotent stem cell platform. Pluripotent cells are a type of stem cell capable of becoming all of the cell types in the human body. From its immunotherapy platform, the Company is developing over two programs. AST-VAC1 (telomerase loaded, autologous dendritic cells), which allows patient's own cells to recognize and fight cancer cells in acute myelogenous leukemia (AML). Together with Cancer Research United Kingdom (CRUK), it is developing AST-VAC2 (telomerase loaded, -allogeneic dendritic cells), -derived from pluripotent stem cells. From its pluripotent stem cell platform, it is developing AST-OPC1, oligodendrocyte progenitor cells.

Directors
Last Annual December 31st, 2017
Last Interim September 30th, 2018
Incorporated September 24, 2012
Public Since July 17, 2014
No. of Shareholders: 482
No. of Employees: 31
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange NYSE MKT
Shares in Issue 55,658,684
Free Float (0.0%)
Eligible for
ISAs
SIPPs
AST Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for AST
Upcoming Events for AST
Frequently Asked Questions for Asterias Biotherapeutics Inc
What is the Asterias Biotherapeutics Inc share price?

As of 07/03/19, shares in Asterias Biotherapeutics Inc are trading at $0.945, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Asterias Biotherapeutics Inc share price performed this year?

Shares in Asterias Biotherapeutics Inc are currently trading at $0.945 and the price has moved by -51.54% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Asterias Biotherapeutics Inc price has moved by -66.21% over the past year.

What are the analyst and broker recommendations for Asterias Biotherapeutics Inc?

Of the analysts with advisory recommendations for Asterias Biotherapeutics Inc, there are there are currently 0 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Asterias Biotherapeutics Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Asterias Biotherapeutics Inc next release its financial results?

Asterias Biotherapeutics Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2019-09-30
What is the Asterias Biotherapeutics Inc dividend yield?

Asterias Biotherapeutics Inc does not currently pay a dividend.

Does Asterias Biotherapeutics Inc pay a dividend?

Asterias Biotherapeutics Inc does not currently pay a dividend.

When does Asterias Biotherapeutics Inc next pay dividends?

Asterias Biotherapeutics Inc does not currently pay a dividend.

How do I buy Asterias Biotherapeutics Inc shares?

To buy shares in Asterias Biotherapeutics Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Asterias Biotherapeutics Inc?

Shares in Asterias Biotherapeutics Inc are currently trading at $0.945, giving the company a market capitalisation of £n/a.

Where are Asterias Biotherapeutics Inc shares listed? Where are Asterias Biotherapeutics Inc shares listed?

Here are the trading details for Asterias Biotherapeutics Inc:

Country of listing: United States
Exchange: ASQ
Ticker Symbol: AST
What kind of share is Asterias Biotherapeutics Inc?

We were not able to load our ranking data for Asterias Biotherapeutics Inc

Is there a Asterias Biotherapeutics Inc share price forecast 2021?

We were not able to load any forecast data for Asterias Biotherapeutics Inc.

How can I tell whether the Asterias Biotherapeutics Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Asterias Biotherapeutics Inc. Over the past six months, the relative strength of its shares against the market has been -44.93%. At the current price of $0.945, shares in Asterias Biotherapeutics Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Asterias Biotherapeutics Inc PE Ratio?

We were not able to find PE ratio data for Asterias Biotherapeutics Inc.

Who are the key directors of Asterias Biotherapeutics Inc?

We were unable to find the directors for Asterias Biotherapeutics Inc.

Who are the major shareholders of Asterias Biotherapeutics Inc?

Here are the top five shareholders of Asterias Biotherapeutics Inc based on the size of their shareholding:

Similar to AST
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.